Dear editor,The pandemic of coronavirus disease-19(COVID-19)has lasted for more than three years,causing lots of extra death and posing a serious threat to public health.This pandemic swept the last global safety isla...
supported by grants from the National Key R&D Program of China(2021YFC2301700);National Natural Science Foundation of China(82061138021);the Key Biosafety Science and Technology Program of Hubei Jiangxia Laboratory(JXBS001);Hubei Natural Science Foundation for Distinguished Young Scholars(2021CFA050).
Neutralizing monoclonal antibodies(mAb)are a major therapeutic strategy for the treatment of severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)infection.The continuous emergence of new SARS-CoV-2 variants wor...
This work was supported by the National key R&D program of China(2017YFA0505801);the National Natural Science Foundation of China(11831015)。
Respiratory syncytial virus(RSV) is the major cause of lower respiratory tract infections in children. Inactivated RSV vaccine was developed in the late 1960’s, but the vaccine-enhanced disease(VED) occurred to vacci...
supported by the National Natural Science Foundation of China (Grant number: 81601760, 31621061 and 81461130019);General Financial Grant from the China Postdoctoral Science Foundation (Grant number: 2016M602587);the Shenzhen Foundation of Science and Technology (Grant number: JCYJ20160425 104534335);supported by the Youth Innovation Promotion Association CAS (No.201603)
Feasible and effective cell models for hepatitis B virus(HBV) infection are required for investigating the complete lifecycle of this virus, including the early steps of viral entry. Resistance to dimethyl sulfoxide/p...